Company Filing History:
Years Active: 2002-2009
Title: Innovations by Erika Glusa: Pioneering Treatments for Migraines
Introduction
Erika Glusa is a notable inventor based in Erfurt, Germany. She has made significant contributions to the field of medicine, particularly in the treatment of migraines and related disorders. With a total of 2 patents, her work showcases her dedication to advancing healthcare solutions.
Latest Patents
One of Erika's latest patents focuses on methods of using 1-allyl ergot alkaloid derivatives to treat migraines. This invention relates to 1-allyl ergot alkaloids and their derivatives, which possess selective antagonistic properties to 5-HT receptors. These properties are crucial for the prevention of, and relief from, migraine-related headaches, Parkinson's disease, and disorders of thrombocyte function. Another significant patent involves ergoline amine derivatives that have a blood pressure-lowering effect, further emphasizing her innovative approach to medical treatments.
Career Highlights
Throughout her career, Erika has worked with prominent companies such as Cybio Screening GmbH and Axxonis Pharma AG. Her experience in these organizations has allowed her to develop and refine her inventions, contributing to her reputation as a leading inventor in her field.
Collaborations
Erika has collaborated with several professionals, including Ralf Wyrwa and Albert Haertl. These partnerships have played a vital role in her research and development efforts, enhancing the impact of her innovations.
Conclusion
Erika Glusa's contributions to the field of medicine through her patents demonstrate her commitment to improving healthcare. Her innovative approaches to treating migraines and related disorders highlight her as a significant figure in the world of inventions.